GlassScriptPhysician profile
Jeffry A Mullvain
NPI 1467557454
$6,096.84
in general payments reported to CMS, 2019-2025
32 companies · $700 in 2025
The $700 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,448 · 2020: $509 · 2021: $544 · 2022: $261 · 2023: $924 · 2024: $712 · 2025: $700.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,256 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,255.79 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,698.91 | 2019-2025 | |
| Amgen INC. | $624.16 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $615.18 | 2019-2025 | |
| Abbott Laboratories | $390.98 | 2019-2025 | Mitraclip, Jot Dx, Aveir |
| E.R. Squibb & Sons, L.L.C. | $286.51 | 2019-2025 | Camzyos, Eliquis |
| Janssen Pharmaceuticals, INC | $283.41 | 2019-2023 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.96 | 2019-2025 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $206.50 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $203.62 | 2019-2025 | Brilinta, Farxiga |
| Medtronic, INC. | $193.05 | 2021-2025 | Aurora Ev-Icd Mri Surescan, Linq II, Mycarelink |
| Amarin Pharma, INC. | $184.38 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $181.86 | 2019-2025 | Evkeeza |
| Glaxosmithkline, LLC. | $117.82 | 2019 | |
| Sanofi-Aventis U.S. LLC | $115.66 | 2019-2020 | |
| Boston Scientific Corporation | $97.96 | 2020-2025 | Lux-Dx Insertable Cardiac Monitor |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $80.08 | 2024-2025 | Ozempic, Rybelsus, Norditropin |
| Biotronik INC. | $75.61 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $67.04 | 2019-2023 | Uptravi, Opsumit |
| Philips North America LLC | $59.06 | 2019-2023 | |
| Irhythm Technologies, INC. | $58.23 | 2022-2023 | Zio Xt Patch |
| Allergan, INC. | $45.58 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $41.38 | 2024 | Arcalyst |
| Infobionic, INC | $36.55 | 2025 | Mome Device |
| Bayer Healthcare Pharmaceuticals INC. | $33.01 | 2024 | |
| Kowa Pharmaceuticals America, INC. | $30.86 | 2019 | |
| Gilead Sciences, INC. | $27.06 | 2019 | |
| Radius Health, INC. | $24.65 | 2019 | |
| W. L. Gore & Associates, INC. | $18.89 | 2020 | |
| Medtronic Vascular, INC. | $18.57 | 2019 | |
| Cvrx, INC. | $17.81 | 2025 | Barostim Neo System |
| Esperion Therapeutics, INC. | $17.52 | 2024 | Nexletol |
| Lilly USA, LLC | $13.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffry Mullvain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.